@FiercePharma: Teva UK pulls batches of generic Clarinex on impurities in tablets. More | Follow @FiercePharma
@EricPFierce: Capsule maker Qualicaps expanding in NC as it transitions to new ownership. News | Follow @EricPFierce
@AlisonBFierce: Dynavax will shoot for a limited approval of hep B vaccine Heplisav. The FDA nixed the product over safety issues. Report | Follow @AlisonBFierce
> Bayer plans a dividend of €1.90 ($2.51) per share, higher than the €1.82 ($2.38) expected by analysts. Report
> Johnson & Johnson ($JNJ) will take a $100 million charge against first-quarter profits because of Venezuela's currency devaluation. Report
> Amarin ($AMRN) asked the FDA to approve a new use for its blood-lipid treatment Vascepa, derived from fish oil. Release
> Fresenius Kabi's injectable drugs business is giving its parent company a boost; Fresenius SE expects 2013 profits to top €1 billion ($1.31 billion) on the unit's growth. Report
> Nestlé's health science unit bought the "medical foods" firm Pamlab, which makes products for patients with conditions such as diabetes, dementia and depression. Report
> Chemerix tapped former Glaxo Holdings CEO Ernest Mario to be chairman of the board. Report
> Mylan ($MYL) launched its version of AbbVie's ($ABBV) Tricor, a cholesterol fighter known generically as fenofibrate. Report
@FierceMedDev: NeuroPace wins FDA panel vote for epilepsy implant. More | Follow @FierceMedDev
@MarkHFierce: A blood Dx to determine suicide risk? It's possible, and researchers will have a test ready for trials in a year. Story | Follow @MarkHFierce
@DamianFierce: J&J has to fork over $3.4M in its first vaginal mesh verdict. Roughly 2,100 more lawsuits to go. Report | Follow @DamianFierce
> Abbott lops off another 450 jobs at stent plant. Article
> Mindray milestone: $1B in revenue in 2012. Item
> TearScience wins $70M funding commitment for dry eye device. Story
Biotech News
@FierceBiotech: AstraZeneca claims PhIII sweep for OIC drug as CV concerns linger. News | Follow @FierceBiotech
@JohnCFierce: Officials prepare to dismantle patent rules that stifle drug R&D. Report | Follow @JohnCFierce
@RyanMFierce: Miami biotech Brickell revealed $7M B round for dermatology drug development. Florida a good spot for this company? Release | Follow @RyanMFierce
> Sanofi's Zerhouni, analysts warn sequestration could cripple R&D. Article
> Cosmetics group leads $7M round for dermatology upstart Brickell. Story
Biotech Research News
@EmilyMFierce: Retargeted bird virus could provide new treatment for prostate cancer. News | Follow @EmilyMFierce
> Therapeutic could heal wounds faster. Story
> New drug combo stops head and neck cancer in mice. Report
> Facebook, Google founders award $33M to life scientists. Item
> Obama administration plans brain-mapping project. More
Pharma Manufacturing News
> Teva repeats recall after getting batch numbers wrong. More
> Affymax explores manufacturing for ties to fatal drug reactions. Story
> Qualicaps expanding plant as Mitsubishi takes ownership. News
> Manufacturing continues to undercut Ranbaxy. Article
And Finally... Just one week of poor sleep can cause genetic changes that might lead to disease. Report